Lee Kenneth B Jr - Net Worth and Insider Trading

Lee Kenneth B Jr Net Worth

The estimated net worth of Lee Kenneth B Jr is at least $204,961 dollars as of 2024-09-18. Lee Kenneth B Jr is the Director of BioCryst Pharmaceuticals Inc and owns about 24,252 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $192,076. Lee Kenneth B Jr is also the Director of Eyenovia Inc and owns about 25,359 shares of Eyenovia Inc (EYEN) stock worth over $12,885. Details can be seen in Lee Kenneth B Jr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lee Kenneth B Jr has not made any transactions after 2021-09-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Lee Kenneth B Jr

To

Lee Kenneth B Jr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lee Kenneth B Jr owns 6 companies in total, including Eyenovia Inc (EYEN) , BioCryst Pharmaceuticals Inc (BCRX) , and PhaseBio Pharmaceuticals Inc (PHASQ) among others .

Click here to see the complete history of Lee Kenneth B Jr’s form 4 insider trades.

Insider Ownership Summary of Lee Kenneth B Jr

Ticker Comapny Transaction Date Type of Owner
EYEN Eyenovia Inc 2021-06-15 director
BCRX BioCryst Pharmaceuticals Inc 2021-09-13 director
PHASQ PhaseBio Pharmaceuticals Inc 2018-10-17 10 percent owner
LIMIT LIMIT 2017-05-22 10 percent owner
LIMIT LIMIT 2017-05-11 director
LIMIT LIMIT 2016-06-01 10 percent owner

Lee Kenneth B Jr Latest Holdings Summary

Lee Kenneth B Jr currently owns a total of 2 stocks. Among these stocks, Lee Kenneth B Jr owns 24,252 shares of BioCryst Pharmaceuticals Inc (BCRX) as of September 13, 2021, with a value of $192,076 and a weighting of 93.71%. Lee Kenneth B Jr also owns 25,359 shares of Eyenovia Inc (EYEN) as of June 15, 2021, with a value of $12,885 and a weighting of 6.29%.

Latest Holdings of Lee Kenneth B Jr

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BCRX BioCryst Pharmaceuticals Inc 2021-09-13 24,252 7.92 192,076
EYEN Eyenovia Inc 2021-06-15 25,359 0.51 12,885

Holding Weightings of Lee Kenneth B Jr


Lee Kenneth B Jr Form 4 Trading Tracker

According to the SEC Form 4 filings, Lee Kenneth B Jr has made a total of 2 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 6,000 shares on September 13, 2021, which brought Lee Kenneth B Jr around $92,100.

According to the SEC Form 4 filings, Lee Kenneth B Jr has made a total of 1 transactions in Eyenovia Inc (EYEN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Eyenovia Inc is the acquisition of 6,000 shares on June 15, 2021, which cost Lee Kenneth B Jr around $32,520.

Insider Trading History of Lee Kenneth B Jr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lee Kenneth B Jr Trading Performance

GuruFocus tracks the stock performance after each of Lee Kenneth B Jr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lee Kenneth B Jr is 27.87%. GuruFocus also compares Lee Kenneth B Jr's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lee Kenneth B Jr within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Lee Kenneth B Jr's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Lee Kenneth B Jr

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 36.75 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 34.31 LIMIT LIMIT LIMIT LIMIT LIMIT

Lee Kenneth B Jr Ownership Network

Ownership Network List of Lee Kenneth B Jr

No Data

Ownership Network Relation of Lee Kenneth B Jr

Insider Network Chart

Lee Kenneth B Jr Owned Company Details

What does Eyenovia Inc do?

Who are the key executives at Eyenovia Inc?

Lee Kenneth B Jr is the director of Eyenovia Inc. Other key executives at Eyenovia Inc include director & Chief Executive Officer Michael M Rowe , 10 percent owner Stuart M. Grant , and Chief Financial Officer John P Gandolfo .

Eyenovia Inc (EYEN) Insider Trades Summary

Over the past 18 months, Lee Kenneth B Jr made no insider transaction in Eyenovia Inc (EYEN). Other recent insider transactions involving Eyenovia Inc (EYEN) include a net purchase of 1,839,115 shares made by Stuart M. Grant , a net sale of 270,000 shares made by Tsontcho Ianchulev , and a net purchase of 84,498 shares made by Michael M Rowe .

In summary, during the past 3 months, insiders sold 0 shares of Eyenovia Inc (EYEN) in total and bought 1,592,222 shares, with a net purchase of 1,592,222 shares. During the past 18 months, 270,000 shares of Eyenovia Inc (EYEN) were sold and 1,949,933 shares were bought by its insiders, resulting in a net purchase of 1,679,933 shares.

Eyenovia Inc (EYEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eyenovia Inc Insider Transactions

No Available Data

Lee Kenneth B Jr Mailing Address

Above is the net worth, insider trading, and ownership report for Lee Kenneth B Jr. You might contact Lee Kenneth B Jr via mailing address: 7100 West Credit Avenue, Suite 101, C/o Aralez Pharmaceuticals Inc., Mississauga A6 L5n 0e4.

Discussions on Lee Kenneth B Jr

No discussions yet.